dc.contributorUniversidade Estadual Paulista (Unesp)
dc.contributorUniversidade Estadual de Campinas (UNICAMP)
dc.date.accessioned2014-05-27T11:21:14Z
dc.date.accessioned2022-10-05T17:54:58Z
dc.date.available2014-05-27T11:21:14Z
dc.date.available2022-10-05T17:54:58Z
dc.date.created2014-05-27T11:21:14Z
dc.date.issued2004-12-01
dc.identifierRomanian Journal of Gastroenterology, v. 13, n. 4, p. 291-297, 2004.
dc.identifier1221-4167
dc.identifierhttp://hdl.handle.net/11449/68035
dc.identifier2-s2.0-11844289557
dc.identifier6322604200510676
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3917618
dc.description.abstractBackground/Aims. Chronic hepatitis by HCV is progressive towards cirrhosis, with variable rate. We evaluated the rate of fibrosis progression (RFP), risk factors associated with advanced fibrosis (F3 and F4), and estimated the evolution time to cirrhosis. Methods. We transversely selected 142 blood donors infected only with HCV, with a known route of infection, submitted to liver biopsy at admission. RFP= ratio between stage of fibrosis (METAVIR)/estimated duration of infection in years. Non-parametric tests and logistic regression analysis, with significance level of 5% were used. Results. Median RFP was 0.086 U/year (0.05 - 0.142). Ten patients had F4 and 25 had F3. Median RFP values were significantly different (p=0.001) from one age group at contamination to the others and ALT and AST levels. There were no differences in the expected evolution to cirrhosis between intermediate fibrosers (F2) and the rapid fibrosers (F3 and F4). The independent variables associated with advanced fibrosis were ALT (OR 7.2) and GGT (OR 6.4) and age at inclusion (OR 1.12). Conclusion. This study suggests that RFP is extremely variable, it is exponential with age, and mainly influenced by host characteristics, especially age at contamination and possibly ethnical group. These asymptomatic patients had high percentage of fibrosis F2, F3 and F4.
dc.languageeng
dc.relationRomanian Journal of Gastroenterology
dc.rightsAcesso restrito
dc.sourceScopus
dc.subjectChronic hepatitis C
dc.subjectFibrosis progression
dc.subjectRisk factors
dc.subjectalanine aminotransferase
dc.subjectalcohol
dc.subjectaspartate aminotransferase
dc.subjectgamma glutamyltransferase
dc.subjectvirus RNA
dc.subjectadult
dc.subjectage
dc.subjectalcohol consumption
dc.subjectblood donor
dc.subjectblood transfusion
dc.subjectcontrolled study
dc.subjectdisease course
dc.subjectdisease duration
dc.subjectethnic group
dc.subjectfemale
dc.subjecthepatitis C
dc.subjectHepatitis C virus
dc.subjecthistopathology
dc.subjecthuman
dc.subjectintravenous drug abuse
dc.subjectliver biopsy
dc.subjectliver fibrosis
dc.subjectlogistic regression analysis
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectnonparametric test
dc.subjectrisk factor
dc.subjectviral contamination
dc.subjectAdult
dc.subjectBlood Donors
dc.subjectDisease Progression
dc.subjectFemale
dc.subjectHepatitis C, Chronic
dc.subjectHumans
dc.subjectLiver Cirrhosis
dc.subjectLogistic Models
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectMultivariate Analysis
dc.subjectRisk Factors
dc.subjectStatistics, Nonparametric
dc.titleProgression of liver fibrosis in blood donors infected with hepatitis C virus
dc.typeArtigo


Este ítem pertenece a la siguiente institución